Substance / Medication

Calcium gluconate

Overview

Active Ingredient
calcium gluconate
RxNorm CUI
1908

Indications

Calcium Gluconate Injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use The safety of Calcium Gluconate Injection for long term use has not been established.

Labeler: WG Critical Care, LLCUpdated: 2026-02-17T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Calcium gluconate injection is contraindicated in: •Hyperca lcemia [see Warnings and Precautions (5.2)] • Neonates (28 days of age or younger) receiving ceftriaxone

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

6 trials linked to this intervention

6
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
The effect of intravenous calcium gluconate on the prevention of ovarian hyperstimulation syndrome. (A randomized clinical trial).
Lotfalizadeh Marzieh, Khadem Nayereh, Sadeghi Tahere et al. · J Gynecol Obstet Hum Reprod · 2024
PMID: 39293587RCT
Intravenous calcium Gluconate alleviates Lead-induced abdominal pain, a randomized clinical trial.
Mayel Masoud, Hamzeh Saleh, Rabori Salile Shahabi et al. · BMC Pharmacol Toxicol · 2020
PMID: 32188492RCTFull text (PMC)
Effectiveness of intra-articular injections of sodium bicarbonate and calcium gluconate in the treatment of osteoarthritis of the knee: a randomized double-blind clinical trial.
García-Padilla Sandra, Duarte-Vázquez Miguel Angel, Gonzalez-Romero Karla Elena et al. · BMC Musculoskelet Disord · 2015
PMID: 25963758RCTFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Calcium gluconate (substance)
SNOMED CT
387292008
UMLS CUI
C0006699
RxNorm CUI
1908
Labeler
WG Critical Care, LLC

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

6
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
6
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.